Dr Samantha Philip and Dr Kathryn E Kyler discuss the impact of weight bias in healthcare and ways for physicians to be more ...

New opioid labeling requirements will better highlight the risks of long-term use, including misuse, addiction, and overdose.

The FDA has approved a labeling update for Leqvio (inclisiran) allowing for first-line use in the treatment of hypercholesterolemia.

Among patients with chronic hepatitis C virus (HCV), post-sustained virologic response (SVR) hepatocellular carcinoma (HCC) risk is significantly higher with metabolic dysfunction-associated steatotic ...

The USPSTF recommends screening adults unhealthy alcohol use in primary care settings and providing brief behavioral counseling interventions.

The Bill and Melinda Gates Foundation will invest $2.5 billion in research on gynecological health, obstetrics, and contraceptive innovation.

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.

The Trump administration plans to overturn a 2022 rule change allowing the VA to provide abortions in certain cases.

Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...

Orfoglipron was associated with improved glycemic control and weight reduction among patients with early-stage type 2 ...

Doehler Dry Ingredient Solutions, LLC is recalling some 15-count boxes of “Member’s Mark Freeze Dried Fruit Variety Pack” after internal testing found the presence of Listeria monocytogenes, the U.S.

The recombinant zoster vaccine significantly lowers the risk for shingles complications among individuals with IBD.